Functional expression of CD73 on human natural killer cells

Area of Science:

• Immunology
• Cancer Biology
• Tumor Microenvironment

Background:

• CD73 on cancer cells promotes immune evasion by producing adenosine, an immunosuppressive molecule.
• The role and extent of CD73 expression on natural killer (NK) cells remain unclear.
• Previous studies suggested NK cells might overexpress CD73, but this has not been consistently demonstrated.

Purpose of the Study:

• To investigate the conditions and extent of CD73 upregulation on NK cells.
• To determine if CD73 expression on NK cells correlates with specific functional characteristics.
• To explore the in vivo relevance of CD73 expression on tumor-infiltrating NK cells.

Main Methods:

• Exposure of NK cells to CD73-expressing cancer cells.
• Analysis of NK cell CD73 surface expression under varying conditions (e.g., hypoxia).
• In vitro functional assays comparing CD73+ and CD73- NK cells.
• Analysis of patient data (glioblastoma) for NK cell marker expression.

Main Results:

• NK cells can upregulate CD73 surface expression in response to CD73+ cancer cells, but this is cancer-specific and environmentally influenced (e.g., hypoxia).
• Upregulation is not universal and often limited in intensity.
• CD73+ NK cells exhibited hyperfunctional characteristics in vitro.
• Glioblastoma patient data revealed variable NK cell CD73 expression, associated with altered expression of CD16, CEACAM1, CXCR3, and TIM-3.

Conclusions:

• NK cells are generally resistant to substantial CD73 upregulation.
• Inducible CD73 expression on NK cells is driven by cancer cell CD73 and microenvironmental factors like hypoxia.
• NK cells expressing CD73 demonstrate distinct functional signatures, suggesting a role in immune modulation within the tumor microenvironment.